Market Place
Sourcing Support
All News #Library
Generics
Astellas’ generic Myrbetriq defence knocked back again
20 Apr 2024 //
PHARMAPHORUM
Appeals court sides with Pfizer in patent fight with Astellas
05 Jan 2023 //
FIERCE PHARMA
Pfizer, Astellas` Xtandi matches J&J`s Erleada with new FDA nod
17 Dec 2019 //
FIERCE PHARMA
J&J finds competitive edge with latest Erleada approval
19 Sep 2019 //
BIOPHARMADIVE
Glenmark Pharma gets USFDA nod for overactive bladder treatment drug
20 May 2019 //
MONEYCONTROL
Mycamine® (micafungin sodium): Astellas Pharma vs. Xellia Pharmaceuticals
24 Nov 2018 //
PATENT LITIGATION
U.S. appeals court declines J&J bid to stop generic Zytiga sales
22 Nov 2018 //
REUTERS
Jardiance (empagliflozin) : Boehringer Ingelheim vs. Zydus Pharms
20 Nov 2018 //
PATENT LITIGATION
Lexiscan (regadenoson) : Astellas Pharma, Gilead Sciences vs. Apotex
01 Nov 2018 //
PATENT LITIGATION
Vesicare® (Solifenacin Succinate) : Astellas Pharma Inc. v. Aurobindo Pharma
25 Jun 2018 //
PATENT LITIGATION
VESIcare® (Solifenacin): Astellas Pharma Inc v. Cipla
05 Jun 2018 //
PATENT LITIGATION
CHMP recommends Teva`s generic version of Astellas` Advagraf
16 Oct 2017 //
PMLIVE
Astellas Sues Roxane Over Generic Cancer Drug ANDA
12 May 2017 //
LAW360
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.